Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

MEPOLIZUMAB for Obesity: Side Effects & Safety Data

Lose Weight Fast — The 21-Day Smoothie Diet

36 fat-burning recipes + shopping lists. Results in the first week.

Get the Program

There are 6 adverse event reports in the FDA FAERS database where MEPOLIZUMAB was used for Obesity.

Most Reported Side Effects for MEPOLIZUMAB

Side Effect Reports % Deaths Hosp.
Asthma 11,033 25.7% 290 6,026
Dyspnoea 9,192 21.4% 567 4,811
Wheezing 6,093 14.2% 552 3,335
Product dose omission issue 5,873 13.7% 88 957
Cough 4,577 10.6% 46 2,079
Pneumonia 4,107 9.6% 577 2,517
Therapeutic product effect incomplete 4,106 9.6% 347 2,064
Drug ineffective 3,880 9.0% 565 1,808
Loss of personal independence in daily activities 3,566 8.3% 179 2,015
Fatigue 2,656 6.2% 479 1,221
Off label use 2,614 6.1% 788 938
Sleep disorder due to a general medical condition 2,574 6.0% 104 1,406
Malaise 2,445 5.7% 392 1,248
Condition aggravated 2,304 5.4% 581 1,224
Headache 2,290 5.3% 379 951

Other Indications for MEPOLIZUMAB

Asthma (26,352) Product used for unknown indication (13,798) Eosinophilic granulomatosis with polyangiitis (1,224) Nasal polyps (757) Illness (372) Hypereosinophilic syndrome (351) Chronic obstructive pulmonary disease (291) Chronic rhinosinusitis with nasal polyps (122) Eosinophilia (102) Chronic sinusitis (71)

Other Drugs Used for Obesity

SEMAGLUTIDE (2,586) LIRAGLUTIDE (1,090) BUPROPION\NALTREXONE (726) TIRZEPATIDE (700) ORLISTAT (163) PHENTERMINE (127) DULAGLUTIDE (109) METFORMIN (100) PHENTERMINE\TOPIRAMATE (86) TOPIRAMATE (86)

Related Pages

MEPOLIZUMAB Full Profile All Obesity Drugs MEPOLIZUMAB Demographics MEPOLIZUMAB Timeline